Bacterial lipopolysaccharides and phospholipids — Drug Target

All drugs that target Bacterial lipopolysaccharides and phospholipids — marketed and clinical-stage. Includes 1 drug classes acting on this target.

Drug classes

Polymyxin antibiotic

Marketed (2)

• Polymyxin e · Mahmoud I Mostafa · Polymyxin antibiotic · Infectious Disease
  Polymyxin E (colistin) disrupts bacterial cell membranes by binding to lipopolysaccharides and phospholipids, causing cell lysis and death.
• Standard Dose Colistin · King Saud Medical City · Polymyxin antibiotic · Infectious Disease
  Colistin disrupts bacterial cell membranes by binding to lipopolysaccharides and phospholipids, causing cell lysis and death.

Phase 3 pipeline (1)

• Coly Mycin M Injectable Product · Chia Tai Tianqing Pharmaceutical Group Co., Ltd. · Polymyxin antibiotic · Infectious Disease
  Colistin (polymyxin E) is a cyclic polypeptide antibiotic that disrupts bacterial cell membranes by binding to lipopolysaccharides and phospholipids, leading to cell lysis and death.